A World Health Organization report reveals that 10 firms control 78% of vaccine volume and reasons innovative tech remains ...

As antibiotic-resistant infections rise and are projected to cause up to 10 million deaths per year by 2050, scientists are ...

The Life Science Community(TM), a leading B2B digital media platform serving the pharma, biotech, medtech, healthcare and research industries, today released its Xtalks 2025 Wrapped report, ...

Researchers at the Federal University of São Paulo (UNIFESP) in Brazil have discovered that SARS-CoV-2, the virus that causes ...

From COVID-19 to the seasonal flu and RSV, vaccinations for respiratory viruses are typically delivered via intramuscular injection, which generates antibodies in the bloodstream. But the first line ...

From COVID-19 to the seasonal flu and RSV, vaccinations for respiratory viruses are typically delivered via intramuscular injection, which generates ...

Rising demand for gene and cell therapies, expanding mRNA vaccine pipelines, and increasing investments in GMP-compliant manufacturing facilities are driving growth in the viral vectors and plasmid ...

Replicate Bioscience, a clinical-stage company pioneering novel self-replicating RNA (srRNA) technology for applications across infectious disease, immunology, and other therapeutic areas, today ...

Glioma remains one of the most challenging malignancies of the central nervous system, characterized by a highly ...

Viruses are typically described as tiny, perfectly geometric shells that pack genetic material with mathematical precision, ...

Kelonia Therapeutics' KLN-1010 has shown promising early results in a phase 1 trial for relapsed or refractory multiple ...

Houston Methodist Research Institute is collaborating with the Coalition for Epidemic Preparedness Innovations (CEPI) and leading scientific institutions in the Republic of Korea to develop what could ...